|
NOSIP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.26589999999804E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.232800E-04 |
| Normal-vs-Stage2 |
3.712200E-02 |
| Normal-vs-Stage3 |
3.695800E-03 |
| Normal-vs-Stage4 |
1.443880E-03 |
| Stage1-vs-Stage2 |
2.656000E-01 |
| Stage1-vs-Stage3 |
1.264370E-01 |
| Stage1-vs-Stage4 |
4.336800E-01 |
| Stage2-vs-Stage3 |
9.080800E-01 |
| Stage2-vs-Stage4 |
6.292600E-01 |
| Stage3-vs-Stage4 |
4.245000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.179600E-04 |
| Normal-vs-AfricanAmerican |
1.97677999999035E-05 |
| Normal-vs-Asian |
1.337790E-01 |
| Caucasian-vs-AfricanAmerican |
5.004500E-02 |
| Caucasian-vs-Asian |
5.247800E-01 |
| AfricanAmerican-vs-Asian |
8.904200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.048200E-04 |
| Normal-vs-Female |
1.391360E-04 |
| Male-vs-Female |
3.868000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.121500E-02 |
| Normal-vs-Age(41-60Yrs) |
8.01980000000313E-05 |
| Normal-vs-Age(61-80Yrs) |
1.799160E-03 |
| Normal-vs-Age(81-100Yrs) |
1.296800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.371600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.160600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.958200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.877000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.412800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.702800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.13819999999032E-05 |
| Normal-vs-Grade 2 |
1.162840E-03 |
| Normal-vs-Grade 3 |
5.166200E-04 |
| Normal-vs-Grade 4 |
1.120080E-02 |
| Grade 1-vs-Grade 2 |
2.079400E-01 |
| Grade 1-vs-Grade 3 |
3.241800E-02 |
| Grade 1-vs-Grade 4 |
3.335600E-02 |
| Grade 2-vs-Grade 3 |
2.041600E-01 |
| Grade 2-vs-Grade 4 |
2.072400E-01 |
| Grade 3-vs-Grade 4 |
8.501600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.08610000000431E-05 |
| Normal-vs-ccB subtype |
3.187000E-01 |
| ccA subtype-vs-ccB subtype |
1.463400E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.939800E-03 |
| Normal-vs-N1 |
4.032200E-01 |
| N0-vs-N1 |
5.376600E-01 |
|
|
